SLC3A2 and breast cancer: Importantly, malignant breast cancer tissues exhibited higher protein levels of SLC7A11 and SLC3A2 compared to benign breast tissues (Fig. 3H, I), indicating a positive association of SLC7A11 and SLC3A2 levels with poor prognosis in breast cancer patients.